Riskpilot← Back to searchSign inGet full accessKAG Läkartjänst AB
ABActiveOrg 5568536337Bokbindarevägen 2General medical practice activities · NACE 8621Est. 20111 employees
Revenue 2025
SEK 1,7M
+165% vs 2024
EBITDA margin
94.7%
+729% vs 2024
Equity ratio
76.7%
Financial strength
Net profit 2025
SEK 1,3M
+722% vs 2024
| Revenue | SEK 1,7M | +165% |
| EBITDA | SEK 1,6M | +729% |
| Net profit | SEK 1,3M | +722% |
| Total assets | SEK 1,8M | +415% |
| Equity | SEK 1,3M | +551% |
| Employees | 1 | — |
Legal name
KAG Läkartjänst AB
Org number
5568536337
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
20 maj 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva hälso- och sjukvård, samt driva därmed förenlig verksamhet. Bolaget skall även äga och förvalta fast och lös egendom.
Address
Bokbindarevägen 2
Phone
+46703629278
Email
khalil6284@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 502 | 650 | 1 721 |
| Staff expenses | — | — | — | −434 | −56 |
| EBITDA | — | — | 342 | 196 | 1 629 |
| Depreciation & amort. | −0 | −0 | −0 | — | — |
| EBIT | 0 | 0 | 342 | 196 | 1 629 |
| Net financials | — | — | — | 2 | −2 |
| Profit before tax | 0 | 0 | 342 | 198 | 1 626 |
| Tax | −0 | −0 | −70 | −41 | −336 |
| Net profit | 0 | 0 | 272 | 157 | 1 291 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 | 30 | 529 | 341 | 1 758 |
| Equity | 4 | 30 | 302 | 207 | 1 348 |
| Long-term debt | 0 | 0 | 2 | 23 | 1 |
| Short-term debt | 0 | 0 | 225 | 112 | 409 |
| Total debt | — | — | 227 | 134 | 410 |
EBITDA margin
94.7%
This company
15.8%
Market median
+499% vs market
20212025
Equity ratio
76.7%
This company
38.2%
Market median
+101% vs market
20212025
Return on equity
95.8%
This company
18.4%
Market median
+421% vs market
20212025
Net profit margin
75.0%
This company
8.1%
Market median
+826% vs market
20212025
Asset turnover
0.98×
This company
1.12×
Market median
+13% vs market
20212025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
PK Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (4) | ||
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KAG Läkartjänst AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pär Karl Erik Hagman | Audit | 0 companies |
| Khalil Abu Galil | Board of Directors | 0 companies |
| Anders Evald Lundell | Board of Directors | 0 companies |
| Anna E Susanne Larsson Mirahmadi | Deputy Board Member | 0 companies |
| Margareta Mari Hjort | Deputy Board Member | 0 companies |
| Mohammad Hussein Mirahmadi | Board of Directors | 0 companies |
| Afef Khadhraoui | Deputy Board Member | 0 companies |